Received Aug 14, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 3 | 93N4J | — |
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | — | — |
Shingrix third dose; Shingrix given inadvertently and intended vaccine to be administered was Arexvy; patient had previously received a late second dose of Shingrix; This non-serious case was reported by a other health professional via call center representative and described the occurrence of extra dose administered in a 62-year-old female patient who received Herpes zoster (Shingrix) (batch number 93N4J, expiry date 25-APR-2027) for prophylaxis. Co-suspect products included Herpes zoster (Shingrix) for prophylaxis and RSVPreF3 adjuvanted (Arexvy) for prophylaxis. Previously administered products included Shingrix (received first dose of Shingrix on 20 Jun 2023). On 09-JUL-2025, the patient received the 3rd dose of Shingrix. On 04-JAN-2024, the patient received the 2nd dose of Shingrix. The patient did not receive Arexvy. On 04-JAN-2024, after receiving Shingrix, the patient experienced drug dose administration interval too long (Verbatim: patient had previously received a late second dose of Shingrix). On 09-JUL-2025, the patient experienced extra dose administered (Verbatim: Shingrix third dose) and wrong vaccine administered (Verbatim: Shingrix given inadvertently and intended vaccine to be administered was Arexvy). The outcome of the extra dose administered, drug dose administration interval too long and wrong vaccine administered were not applicable. Additional Information: GSK Receipt Date: 16-JUL-2025 The reporter reported that while gathering information it was discovered patient had previously received a late second dose of Shingrix. The First dose given on 20 Jun 2023 and second dose on 04 Jan 2024 which led to Drug dose administration interval too long. On 09 Jul 2025 a third dose of the Shingrix vaccine was given to a patient. The third dose of the Shingrix vaccine was given to a patient which led to Extra dose administered. Stated it was given inadvertently and intended vaccine to be administered was Arexvy which led to Wrong vaccine administered.